The Global Next Generation Immunotherapy Market size is projected to grow at a CAGR of around 7.5% during the forecast period, i.e., 2024-29. According to MarkNtel Advisors Study.
Global Next Generation Immunotherapy Market Driver:
Growing Adoption of Chimeric Antigen Receptor (CAR) T-cell Therapy – In recent years, there has been a high demand for chimeric antigen receptor (CAR) T-cell therapy, which has been majorly driven by the rising prevalence of relapsed B-cell acute lymphoblastic leukemia (ALL) and specific non-Hodgkin lymphomas. For instance,
In 2020, according to the GLOBOCON, non-Hodgkin lymphomas (NHL) have been ranked as one of the most common cancers and had an estimated 544,000 new cancer cases and 260,000 cancer deaths in 2020.
The rising demand for CAR-T cell therapy among NHL patients has been majorly attributed to the superior clinical outcomes of chimeric antigen receptor (CAR) T-cell therapy arising from its proven success in treating challenging conditions. In addition, to cater to this rising demand for CAR-T cell therapy, companies have heightened funding into CAR-T cell therapy research & development, which led to the launch of new drugs. For instance,
In 2020, Tecartus, by Kite Pharma Inc., a CAR-T cell therapy was approved by the US FDA, which provided a significant treatment option for relapsed or refractory mantle cell lymphoma, expanding the application of CAR-T cell therapies of non-Hodgkin lymphoma.
Hence, with the availability of better next-generation immunotherapies, the market has experienced considerable growth. Moreover, the regulatory approvals and accelerated pathways granted by regulatory agencies such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have played a crucial role in driving the adoption of CAR-T cell therapy. Hence, the established regulatory framework and clear pathways for approval would further facilitate the development and commercialization of CAR-T cell therapies, which would help in the market growth in the coming years as well.
Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/next-generation-immunotherapy-market.html
Key Market Reports Highlights
· Market Dimensions & Projections
· Pricing Evaluation
· Recent Strategic Moves by Companies
· Primary Stakeholders
· Import/Export Trend Analysis
· Competitive Landscape Assessment
· Emerging Opportunities
· Market Trends and Indicators
*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Browse Full Report including(TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/next-generation-immunotherapy-market.html
Global Next Generation Immunotherapy Market Segmentation:
The market report categorizes the market based on different segments and geographical analysis.
Study Timeline:
-Base Year: 2023
-Historical Period: 2019 to 2022
-Forecast Period: 2024 to 2029
- By Type
- Vaccines- Market Size & Forecast 2019-2029F, USD Million
- mRNA Vaccines- Market Size & Forecast 2019-2029F, USD Million
- DNA Vaccines- Market Size & Forecast 2019-2029F, USD Million
- Protein Vaccines- Market Size & Forecast 2019-2029, USD Million
- Others (Viral Vector Vaccines, Nanoparticle Vaccines, etc.)- Market Size & Forecast 2019-2029, USD Million
- Immune Checkpoint Modulators- Market Size & Forecast 2019-2029F, USD Million
- CAR-T Cell Therapy- Market Size & Forecast 2019-2029F, USD Million
- Tumor-Infiltrating Lymphocytes (TILs) Therapy- Market Size & Forecast 2019-2029F, USD Million
- Bispecific Antibodies- Market Size & Forecast 2019-2029F, USD Million
- Oncolytic Virus Therapy- Market Size & Forecast 2019-2029F, USD Million
- Others (Antibody-drug Conjugates, ACE Inhibitors, etc.)- Market Size & Forecast 2019-2029F, USD Million
- By Route of Administration
- Intravenous- Market Size & Forecast 2019-2029F, USD Million
- Intratumoral- Market Size & Forecast 2019-2029F, USD Million
- Subcutaneous- Market Size & Forecast 2019-2029F, USD Million
- Oral- Market Size & Forecast 2019-2029F, USD Million
- By Therapeutic Area
- Oncology- Market Size & Forecast 2019-2029F, USD Million
- Autoimmune Diseases- Market Size & Forecast 2019-2029F, USD Million
- Infectious Diseases- Market Size & Forecast 2019-2029F, USD Million
- Inflammatory Diseases- Market Size & Forecast 2019-2029F, USD Million
- Others (Neurological Disorders, B-cell Malignancies, etc.) - Market Size & Forecast 2019-2029F, USD Million
- By End User
- Hospitals- Market Size & Forecast 2019-2029F, USD Million
- Specialty Clinics- Market Size & Forecast 2019-2029F, USD Million
- Ambulatory Surgical Centres- Market Size & Forecast 2019-2029F, USD Million
- Cancer Research Centres- Market Size & Forecast 2019-2029F, USD Million
- By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
Competitive Landscape
With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including - Bristol Myers Squibb, Regeneron Pharmaceuticals, MacroGenics, AbbVie Inc., Pfizer Inc., Novartis, Merck & Co., Inc., AstraZeneca, Incyte Corporation, Eli Lilly and Company, Johnson and Johnson, Others are looking forward to strengthening their market positions.
Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/next-generation-immunotherapy-market.html
Data-Driven Insights Backed by Proven Research
We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.
From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us
MarkNtel Advisors
Email: sales@marknteladvisors.com
Website: www.marknteladvisors.com
Latest Press Release - https://www.marknteladvisors.com/press-release
